CD163 and neoplasm: Assessment of tumor immunogenicity by immunohistochemistry revealed the following number of immune cells: CD8+ cells - 11 per 1 mm2, CD68+ – 6 per 1 mm2, CD163+ macrophages – 3 per 1 mm2.